Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

ClinicalTrials.gov ID: NCT06133972

Public ClinicalTrials.gov record NCT06133972. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled Extension Study to Assess the Long-term Safety and Tolerability of Ianalumab in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE Extension)

Study identification

NCT ID
NCT06133972
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
550 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Ianalumab Drug

Drug

Eligibility (public fields only)

Age range
12 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 20, 2024
Primary completion
Apr 7, 2030
Completion
Apr 4, 2032
Last update posted
Jul 7, 2026

2024 – 2032

United States locations

U.S. sites
22
U.S. states
12
U.S. cities
22
Facility City State ZIP Site status
Pinnacle Research Group Llc Anniston Alabama 36207 Recruiting
Providence Medical Center Burbank California 91505 Recruiting
Advanced Medical Research La Palma California 90623 Recruiting
Millennium Clinical Trials Westlake Village California 91361 Active, not recruiting
University of Colorado Denver Aurora Colorado 80045 Recruiting
Clinical Res Of W Florida Clearwater Florida 33765 Recruiting
GNP Research Cooper City Florida 33024 Recruiting
IRIS Research and Development Plantation Florida 33324 Recruiting
Clinical Research of West Florida Inc Tampa Florida 33603 Recruiting
Parris and Associates Rheumatology Lawrenceville Georgia 30044 Recruiting
Robert A Hozman MD SC Skokie Illinois 60076 Recruiting
Willow Rheumatology Wellness Willowbrook Illinois 60527 Recruiting
Accurate Clinical Research Lake Charles Louisiana 70601 Recruiting
University Of Maryland Baltimore Maryland 21201 Active, not recruiting
Henry Ford Health Detroit Michigan 48202 Recruiting
Ahmed Arif Medical Research Center Grand Blanc Michigan 48439 Recruiting
Paramount Med Rsrch and Consult LLC Middleburg Heights Ohio 44130 Recruiting
West Tennessee Research Institute Jackson Tennessee 38305 Recruiting
Shelby Research LLC Memphis Tennessee 38121 Recruiting
Novel Research LLC Bellaire Texas 77401 Terminated
Accurate Clinical Research League City Texas 77573 Recruiting
Epic Medical Research Red Oak Texas 75154 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 121 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06133972, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 7, 2026 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06133972 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →